Harel Insurance Investments & Financial Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
3,048
-527
-15% -$47K ﹤0.01% 304
2026
Q1
$257K Buy
3,575
+3,275
+1,092% +$252K ﹤0.01% 277
2025
Q4
$24K Sell
300
-7,395
-96% -$583K ﹤0.01% 381
2025
Q3
$579K Buy
7,695
+7,395
+2,465% +$507K 0.01% 220
2025
Q2
$21K Hold
300
﹤0.01% 392
2025
Q1
$20K Hold
300
﹤0.01% 411
2024
Q4
$13K Hold
300
﹤0.01% 415
2024
Q3
$19K Hold
300
﹤0.01% 421
2024
Q2
$18K Hold
300
﹤0.01% 445
2024
Q1
$24K Sell
300
-2,950
-91% -$225K ﹤0.01% 428
2023
Q4
$257K Sell
3,250
-668
-17% -$47.5K ﹤0.01% 260
2023
Q3
$274K Buy
3,918
+3,618
+1,206% +$256K 0.01% 251
2023
Q2
$21K Hold
300
﹤0.01% 573
2023
Q1
$22K Hold
300
﹤0.01% 580
2022
Q4
$28K Sell
300
-2,700
-90% -$261K ﹤0.01% 549
2022
Q3
$290K Buy
3,000
+2,700
+900% +$267K 0.01% 266
2022
Q2
$28K Sell
300
-5,840
-95% -$570K ﹤0.01% 603
2022
Q1
$621K Hold
6,140
0.01% 239
2021
Q4
$633K Buy
6,140
+5,840
+1,947% +$540K 0.01% 235
2021
Q3
$25K Sell
300
-9,726
-97% -$815K ﹤0.01% 604
2021
Q2
$2.67M Buy
10,026
+5,378
+116% +$440K 0.06% 160
2021
Q1
$1.12M Sell
4,648
-304
-6% -$22.1K 0.02% 336
2020
Q4
$913K Buy
4,952
+1,001
+25% +$65.1K 0.02% 291
2020
Q3
$231K Buy
3,951
+3,893
+6,712% +$242K 0.01% 291
2020
Q2
$4K Sell
58
-801
-93% -$50.4K ﹤0.01% 487
2020
Q1
$51K Sell
859
-1,846
-68% -$123K ﹤0.01% 272
2019
Q4
$201K Sell
2,705
-6,324
-70% -$444K 0.01% 202
2019
Q3
$569K Buy
9,029
+7,457
+474% +$442K 0.04% 99
2019
Q2
$86K Sell
1,572
-2,459
-61% -$132K ﹤0.01% 263
2019
Q1
$217K Buy
4,031
+2,269
+129% +$140K 0.01% 118
2018
Q4
$115K Buy
1,762
+527
+43% +$39.3K 0.01% 220
2018
Q3
$97K Buy
1,235
+310
+34% +$22.2K ﹤0.01% 274
2018
Q2
$60K Sell
925
-493
-35% -$32.5K ﹤0.01% 289
2018
Q1
$88K Sell
1,418
-10
-0.7% -$717 0.01% 270
2017
Q4
$104K Sell
1,428
-182,319
-99% -$13.3M 0.01% 264
2017
Q3
$14.9M Sell
183,747
-260
-0.1% -$20.6K 1.23% 27
2017
Q2
$14.8M Buy
184,007
+1,260
+0.7% +$99.5K 1.2% 25
2017
Q1
$14.3M Buy
182,747
+1,197
+0.7% +$95.6K 1.26% 24
2016
Q4
$16.2M Hold
181,550
2.29% 12
2016
Q3
$16.2M Sell
181,550
-2,709
-1% -$256K 2.18% 12
2016
Q2
$17.6M Buy
184,259
+2,709
+1% +$270K 2.11% 12
2016
Q1
$18.8M Hold
181,550
2.25% 11
2015
Q4
$17.8M Buy
+181,550
New +$17.8M 2.06% 18

Other funds holding CVS

Harel Insurance Investments & Financial Services's CVS Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $47K and leaving 3,048 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Harel Insurance Investments & Financial Services first reported a position in CVS in Q4 2015 and has held it in 43 quarters since. The position peaked at $18.8M in Q1 2016. 1,281 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 3,048 shares of CVS Health worth $315K as of Q2 2026.
  • Harel Insurance Investments & Financial Services sold 527 CVS Health shares in Q2 2026, an estimated $47K.
  • CVS Health made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #304 holding.
  • Harel Insurance Investments & Financial Services first reported a position in CVS Health in Q4 2015 and has held it in 43 quarters since.
  • Harel Insurance Investments & Financial Services's CVS Health position peaked at $18.8M in Q1 2016.
  • 1,281 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.